It should be noted that the tissue expression of these isoforms is not synonymous with functionality; in particular, the variable expression of OATP1 family members and their genetic variations have been extensively investigated as a possible source of altered pharmacokinetics and pharmacodynamics of anti-cancer drugs. The gene discussed is SLCO1C1; the disease is cancer.